Zenapax (daclizumab) reduces the incidence of acute rejection episodes and improves patient survival following renal transplantation

Autor: Ekberg, H *, Bäckman, L, Tufveson, G, Tydén, G
Zdroj: In Transplantation Proceedings February-March 1999 31(1-2):267-268
Databáze: ScienceDirect